BioCryst Pharmaceuticals
- Country
- Ownership
- -
- Employees
- 536
- Market Cap
- -
- Introduction
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Clinical Trials
88
Active:84
Completed:1
Trial Phases
2 Phases
Phase 1:73
Phase 2:4
Drug Approvals
5
CANADA:2
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (78 trials with phase data)• Click on a phase to view related trials
Phase 1
73 (93.6%)Phase 2
4 (5.1%)1 (1.3%)
No trials found
News
No news found